Kyntra Bio (KYNB) Payables (2016 - 2025)
Historic Payables for Kyntra Bio (KYNB) over the last 12 years, with Q3 2025 value amounting to $5.1 million.
- Kyntra Bio's Payables fell 4486.9% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 million, marking a year-over-year decrease of 4486.9%. This contributed to the annual value of $5.1 million for FY2024, which is 6790.47% down from last year.
- Per Kyntra Bio's latest filing, its Payables stood at $5.1 million for Q3 2025, which was down 4486.9% from $10.5 million recorded in Q2 2025.
- In the past 5 years, Kyntra Bio's Payables registered a high of $71.3 million during Q1 2023, and its lowest value of $4.4 million during Q1 2024.
- In the last 5 years, Kyntra Bio's Payables had a median value of $19.2 million in 2023 and averaged $21.5 million.
- As far as peak fluctuations go, Kyntra Bio's Payables skyrocketed by 87682.95% in 2021, and later crashed by 9389.33% in 2024.
- Kyntra Bio's Payables (Quarter) stood at $26.1 million in 2021, then grew by 17.86% to $30.8 million in 2022, then tumbled by 48.7% to $15.8 million in 2023, then crashed by 67.9% to $5.1 million in 2024, then grew by 0.57% to $5.1 million in 2025.
- Its Payables stands at $5.1 million for Q3 2025, versus $10.5 million for Q2 2025 and $7.3 million for Q1 2025.